Topical Zafirlukast

A Promising New Treatment for Allergic Eye Disorders

Accolade is a development-stage specialty bio-pharmaceutical company focused on developing a range of products for the treatment of atopic and inflammatory allergic conditions. Our team is dedicated to re-purposing Zafirlukast, a known Leukotriene Receptor Antagonist (LTRA) approved and marketed world-wide as Accolate®.
Our initial focus  is re-purposing and use of Zafirlukast for allergic eye disorders.    



©  2020 Accolade Pharma, LLC

42 Hill Road

Wilmington, DE 19806